© 2009 BC Decker Inc                                                                         ACS Surgery: Principles and P...
© 2009 BC Decker Inc                                                                                     ACS Surgery: Prin...
© 2009 BC Decker Inc                                                            ACS Surgery: Principles and Practice
    1...
© 2009 BC Decker Inc                                                                         ACS Surgery: Principles and P...
© 2009 BC Decker Inc                                                                               ACS Surgery: Principles...
© 2009 BC Decker Inc                                                                              ACS Surgery: Principles ...
© 2009 BC Decker Inc                                                                                             ACS Surge...
© 2009 BC Decker Inc                                                                        ACS Surgery: Principles and Pr...
© 2009 BC Decker Inc                                                                              ACS Surgery: Principles ...
© 2009 BC Decker Inc                                                                            ACS Surgery: Principles an...
© 2009 BC Decker Inc                                                                            ACS Surgery: Principles an...
© 2009 BC Decker Inc                                                                              ACS Surgery: Principles ...
© 2009 BC Decker Inc                                                                         ACS Surgery: Principles and P...
© 2009 BC Decker Inc                                                                          ACS Surgery: Principles and ...
© 2009 BC Decker Inc                                                                                               ACS Sur...
A C S0106  Postoperative  Pain
A C S0106  Postoperative  Pain
Upcoming SlideShare
Loading in …5
×

A C S0106 Postoperative Pain

3,818 views

Published on

0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
3,818
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
138
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

A C S0106 Postoperative Pain

  1. 1. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 1 6 POSTOPERATIVE PAIN Spencer S. Liu, MD, and Henrik Kehlet, MD, PHD, FACS (Hon) Clinical Approach to the Patient with Postoperative Pain Postoperative pain con- Guidelines for Postoperative Pain Treatment sists of a constellation of In the past few years, efforts have been made to develop unpleasant sensory, emo- procedure-specific perioperative pain management guide- tional, and mental experi- lines. The impetus for these efforts has been the realization ences associated with that the analgesic efficacy may be procedure dependent autonomic, psychological, and that the choice of analgesia in a given case must also and behavioral responses precipitated by the surgical injury. depend on the benefit-to-risk ratio, which varies among Pain management has received increasing attention, and mul- procedures. In addition, it is clear that some analgesic tiple government agencies and medical specialty organiza- techniques will be considered only for certain specific tions have now created guidelines for treatment of operations (e.g., peripheral nerve blocks and intraperito- postoperative pain.1 In 2001, the Joint Commission on neal local anesthesia).6–8 At present, these procedure- Accreditation of Healthcare Organizations (JCAHO) intro- specific guidelines are still largely in a developmental state duced standards for pain management,2 stating that patients and are available for laparoscopic cholecystectomy, open have the right to appropriate evaluation and management and colon surgery, hysterectomy, inguinal hernia repair, thora- that pain must be assessed. cotomy, mastectomy, hemorrhoidectomy, and knee and Postoperative pain relief has two practical aims. The first hip replacement.9,10 is provision of subjective comfort, which is desirable for humanitarian reasons. The second is inhibition of trauma- thoracic induced nociceptive impulses to blunt autonomic and procedures somatic reflex responses to pain and to enhance subsequent Pain after thoracotomy restoration of function by allowing the patient to breathe, is severe, and pain therapy cough, and move more easily. Because these effects reduce should therefore include a pulmonary, cardiovascular, thromboembolic, and other combination regimen, complications, they may lead secondarily to improved post- preferably comprising epidural local anesthetics and opi- operative outcome. oids11 combined with systemic nonsteroidal antiinflammatory drugs (NSAIDs) or cyclooxygenase-2 (COX-2) inhibitors Inadequate Treatment of Pain (depending on risk factors) [see algorithm]. If the epidural regimen is not available, then comparable analgesia may be A common misconception is that pain, no matter how achieved with continuous thoracic paravertebral block, with severe, can always be effectively relieved by opioid analgesics. It has repeatedly been demonstrated, however, that in a high proportion of postoperative patients, pain is inadequately Table 1 Contributing Causes of Inadequate Pain treated.3,4 This discrepancy between what is possible and Treatment what is practiced can be attributed to a variety of causes [see Insufficient knowledge of drug pharmacology among surgeons and Table 1], which to some extent can be ameliorated by increased nurses teaching efforts. Recent evidence also indicates that overreli- Uniform (p.r.n.) prescriptions ance on opioid therapy may be inherently limiting because of development of both acute tolerance and opioid-induced Lack of concern for optimal pain relief hyperalgesia.5 The ability of opioids in high doses or with Failure to give prescribed analgesics chronic administration to potentially induce pain illustrates Fear of side effects the importance of using multimodal analgesic regimens that Fear of addiction target multiple analgesic pathways. DOI 10.2310/7800.S01C06 01/09
  2. 2. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 2 Combine complementary alternative medicine with pharmalogic and other interventions to treat postoperative pain • Consider recommended multimodal combination regimens. • Acetaminophen is recommended as a basic component of multimodal analgesia in any of the settings listed below. Thoracic Abdominal Cardiac Noncardiac Major Open Give systemic opioids Give epidural analgesia or Give epidural analgesia with NSAIDs or COX-2 continuous paravertebral with NSAIDs or COX-2 inhibitors. block with NSAIDs or inhibitors. Consider epidural COX-2 inhibitors. Secondary Choice: analgesia or parasternal Secondary Choice: Give systemic PCA wound catheter with local Give systemic PCA opioids with NSAIDs or anesthetic. opioids with NSAIDs or COX-2 inhibitors. COX-2 inhibitors. COX-2 = cyclooxygenase-2, NSAIDs = nonsteroidal antiinflammatory drugs; PCA = patient-controlled analgesia. 01/09
  3. 3. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 3 Clinical Approach to the Patient with Postoperative Pain Pelvic Peripheral Prostatectomy Gynecologic Vascular Major Joint Procedures Give epidural analgesia Give systemic PCA Give epidural local Give continuous or single- or systemic PCA opioids opioids with NSAIDs or anesthetics with NSAIDs dose perineural analgesia with NSAIDs or COX-2 COX-2 inhibitors. or COX-2 inhibitors. (femoral or lumbar plexus) inhibitors. Secondary Choice: Secondary Choice: with NSAIDs or COX-2 Give epidural analgesia. Give systemic opioids inhibitors. with NSAIDs or COX-2 Secondary Choice: inhibitors. Give systemic PCA or single-dose spinal opioids with NSAIDs or COX-2 inhibitors. Consider single- dose perineural analgesia. 01/09
  4. 4. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 4 the potential for lesser incidence of urinary retention and Pain relief after major joint procedures (e.g., hip and knee postoperative nausea and vomiting.12 Although comparable, operations)10 may involve an epidural regimen in certain high- the continuous paravertebral technique may be more techni- risk patients because such regimens have been shown to reduce cally difficult. If neither regional analgesic technique is thromboembolic complications and intraoperative blood loss available, then the inferior regimen of NSAIDs and systemic and to improve physical rehabilitation when compared with opioids may be used. Cryoanalgesia is not recommended as systemic opioid regimens.17,18 However, the severe pain noted it is less effective.10 Acetaminophen is recommended as a after knee replacement is probably best treated with peripheral basic analgesic for multimodal analgesia. Pain after cardiac nerve blocks.10,19 Most of the benefit of continuous femoral operation with sternotomy is less severe, and systemic opi- nerve analgesia may also be achieved with a single-injection oids plus NSAIDs are recommended. The combined regi- femoral nerve block.20 Total hip replacement is a less painful men of epidural local anesthetics and opioids or parasternal procedure, but when pain is severe, a continuous lumbar wound catheters with continuous administration of local plexus or femoral nerve block can be used.10,21 Alternatively anesthetics13 is recommended when more effective pain and with less technical expertise, a single intrathecal dose of relief is necessary, and it may reduce cardiopulmonary mor- local anesthetic and low-dose morphine will provide effective bidity and perhaps length of stay.14 analgesia for the first 8 to 16 hours,10 after which NSAIDs or COX-2 inhibitors may be added. Acetaminophen is provided abdominal as a basic analgesic for multimodal analgesia. procedures Pain after major and Treatment Modalities upper open abdominal operations is severe, and a complementary and alternative medicine combined regimen of epi- interventions dural local anesthetics and opioids is recommended because Cognitive, behavioral, alternative, or social interventions it has proved to be superior to systemic opioids and to have should be used in combination with pharmacologic therapies to few and acceptable side effects.10,11,15 Furthermore, the epidu- prevent or control acute pain, with the goal of such interven- ral regimen will reduce postoperative pulmonary complica- tions being to guide the patient toward partial or complete self- tions and ileus compared with treatment with systemic control of pain.22,23 A recent survey by the American Hospital opioids.16 Systemic NSAIDs or COX-2 inhibitors are added Association indicated that 27% of member hospitals offered when needed. Acetaminophen is recommended as a basic complementary and alternative medications (CAMs).24 Use of analgesic for multimodal analgesia. nonpharmacologic adjunctive analgesics has been endorsed by After gynecologic lower abdominal or pelvic operations,10 advisory bodies such as the Anesthesia Patient Safety Founda- systemic opioids plus NSAIDs or COX-2 inhibitors are rec- tion and Institute of Healthcare Improvement.25,26 ommended except in patients in whom more effective pain Psychological preparation in patients with postoperative pain relief is desirable. In such patients, the combined regimen of has been demonstrated to shorten hospital stay and reduce epidural local anesthetics and opioids is preferable. Acet- postoperative narcotic use [see Table 2].27 Guided imagery, aminophen is recommended as a basic analgesic for multi- relaxation, and music techniques have been demonstrated to modal analgesia. reduce postoperative opioid use and affective pain.22 Acupunc- Pain following prostatectomy is usually not severe and may ture and acupressure has been successfully used as an adjunct be treated with systemic opioids combined with NSAIDs or for postoperative analgesia and reduces pain scores, anxiety COX-2 inhibitors and acetaminophen. However, blood loss levels, and postoperative nausea.28 Alternative techniques and thromboembolic complications are reduced when epidu- ral local anesthetics are administered. This method is there- fore recommended intraoperatively and continued in selected Table 2 Psychological Preparation of Surgical Patients high-risk patients for pain relief after open prostatectomy and Procedural information transurethral resection. In low-risk patients, systemic opioids Give a careful and relevant description of what will take place. with NSAIDs or COX-2 inhibitors and acetaminophen allevi- Sensory information ate postoperative pain. Describe the sensations that will be experienced either during or after the operation. peripheral Pain treatment information procedures Outline the plan for administering sedative and analgesic medi- cation and encourage patients to communicate concerns and After vascular proce- discomforts. dures, postoperative pain Instructional information control is probably best Teach patients postoperative exercises, such as leg exercises, achieved with epidural and show them how to turn in bed or move so that pain is local anesthetic–opioid mixtures, combined with systemic minimal. NSAIDs or COX-2 inhibitors.11 Acetaminophen is recom- Reassurance mended as a basic analgesic for multimodal analgesia. This Reassure those who are mentally, emotionally, or physically regimen will be effective, and the increase in peripheral blood unable to cooperate that they are not expected to take an active flow that is documented to occur with epidural local anes- role in coping with pain and will still receive sufficient analgesic treatment. thetics may lower the risk of graft thrombosis. 01/09
  5. 5. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 5 Table 3 Opioid Receptor Types and Physiologic Actions Prototypical Ligand Receptor Type Endogenous Exogenous Physiologic Actions 1 Mu ß-Endorphin Morphine Supraspinal analgesia 2 Mu ß-Endorphin Morphine Respiratory depression Delta Enkephalin — Spinal analgesia Kappa Dynorphin Ketocyclazocine Spinal analgesia, sedation, visceral analgesia should be combined with pharmacologic or other interven- administration of an agonist-antagonist with a complete agonist tions, but care must be taken to ensure that the pharmacologic may cause a reduction in the effect of the complete agonist.29 treatment does not compromise the mental function necessary for the success of the planned psychological intervention. Agents Morphine Morphine is the opioid with which the most systemic opioids clinical experience has been gained. Sufficient pharmacoki- Mechanisms of Action netic and pharmacodynamic data are available. Use of this Opioids produce analgesia and other physiologic effects by agent is recommended; it may be given orally, intravenously binding to specific receptors in the peripheral and central ner- (IV), or intramuscularly (IM). vous system (CNS) [see Table 3]. These receptors normally Meperidine Detailed and sufficient pharmacokinetic bind a number of endogenous substances called opioid pep- and pharmacodynamic data on meperidine are available. It is tides. These receptor-binding interactions mediate a wide array less suitable than morphine as an analgesic because its active of physiologic effects.29 Three types of opioid receptors and their subtypes have been discovered: mu, delta, and kappa Table 4 Intrinsic Activity of Opioids receptors. The most commonly used opioids bind to mu recep- tors. The mu1 receptor is responsible for the production of Opioid Mu Kappa Delta opioid-induced analgesia, whereas the mu2 receptor appears to Agonists be related to the respiratory depression, cardiovascular effects, Morphine Agonist — and inhibition of GI motility commonly seen with opioids. Meperidine Agonist — The discovery of peripheral opioid receptors has led to (Demerol) investigation into potential clinical applications. Phase III studies with alvimopan (a peripheral opioid antagonist that Hydromorphone Agonist (Dilaudid) does not cross the blood-brain barrier) have demonstrated reduced ileus and hospitalization after abdominal surgery.30 Oxymorphone Agonist (Numorphan) Other studies have also investigated the analgesic effects of applying opioids to wound sites in an attempt to provide Levorphanol Agonist peripheral analgesia without central side effects. Unfortunately, (Levo- Dromoran) neither incisional31 nor intra-articular32 opioid administration has demonstrated significant beneficial effect.30 This finding Fentanyl Agonist may be attributable to the need for chronic inflammatory medi- (Duragesic) ators to facilitate expression of peripheral opioid receptors.33 Sufentanil Agonist The relation between receptor binding and the intensity of (Sufenta) the resultant physiologic effect is known as the intrinsic activ- Alfentanil (Alfenta) Agonist ity of an opioid. Most of the commonly used opioid analge- Methadone Agonist sics are agonists. An agonist produces a maximal biologic (Dolophine) response by binding to its receptor. Other opioids, such as Agonist-Antagonists naloxone, are termed antagonists because they compete with agonists for opioid receptor-binding sites. Still other opioids Buprenorphine Partial (Buprenex) agonist are partial agonists because they produce a submaximal response after binding to the receptor. (An excellent example Burtorphanol Antagonist Agonist Agonist of a submaximal response produced by partial agonists is (Stadol) buprenorphine’s action at the mu receptor.) Nalbuphine Antagonist Partial Agonist Drugs such as nalbuphine, butorphanol, and pentazocine are (Nubain) agonist known as agonist-antagonists or mixed agonist-antagonists.29 Pentazocine Antagonist Agonist Agonist These opioids simultaneously act at different receptor sites: their (Talwin) action is agonistic at one receptor and antagonistic at another Dezocine (Dalgan) Partial [see Table 4]. The agonist-antagonists have certain pharmaco- agonist logic properties that are distinct from those of the more common Antagonists mu agonists: (1) they exhibit a ceiling effect and cause only submaximal analgesia compared with mu agonists and (2) Naloxone (Narcan) Antagonist Antagonist Antagonist 01/09
  6. 6. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 6 metabolite, normeperidine, can accumulate, even in patients about 30% of the time during any 4-hour dosing interval. with normal renal clearance, and this accumulation can result The optimal means to treat moderate to severe postoperative in CNS excitation and seizures.29 Other agents should be pain with systemic opioids is via IV patient-controlled anal- used before meperidine is considered. Like morphine, meper- gesia (PCA). This delivery system compensates for the wide idine can be given orally, IV, or IM. inter- and intraindividual variability in analgesic needs and blood levels after opioid administration. Self-delivery helps Side Effects produce timely titration of analgesia and reduces administra- By depressing or stimulating the CNS, opioids cause a tive delay from conventional delivery (e.g., p.r.n.). Systematic number of physiologic effects in addition to analgesia. The reviews have noted that IV PCA delivery of opioids reduces depressant effects of opioids include analgesia, sedation, and pain scores and improves patient satisfaction over conven- altered respiration and mood; the excitatory effects include tional delivery.34 Typical regimens are provided in Table 5. nausea, vomiting, and miosis. Recent advances in iontophoretic technology have led to All mu agonists produce a dose-dependent decrease in the commercial release of a transdermal fentanyl iontophoretic responsiveness of brainstem respiratory centers to increased PCA system. This system delivers 40 µ g fentanyl over carbon dioxide tension (Pco2). This change is clinically man- 10 minutes after patient demand. Onset is rapid because of ifested as an increase in resting Pco2 and a shift in the CO2 the active electrical current driving the fentanyl transder- response curve. Agonist-antagonist opioids have a limited mally. The system deactivates after 24 hours or 80 adminis- effect on the brainstem and appear to elicit a ceiling effect on trations. Several clinical trials have reported equivalence increases in Pco2. between the fentanyl system and IV PCA opioid.35 One Opioids also have effects on the gastrointestinal (GI) tract. pooled analysis suggested less analgesic gaps with the fentanyl Nausea and vomiting are caused by stimulation of the che- system because of fewer technical failures and administrative moreceptor trigger zone of the medulla. Opioids enhance delays than the IV PCA device36; however, the role of this sphincteric tone and reduce peristaltic contraction. Delayed fentanyl system remains to be fully defined. gastric emptying is caused by decreased motility, increased antral tone, and increased tone in the first part of the duode- epidural and subarachnoid opioids num. Delay in passage of intestinal contents because of Opioids were first used in the epidural and subarachnoid decreased peristalsis and increased sphincteric tone leads to spaces in 1979. Since that time, they have become the main- greater absorption of water, increased viscosity, and desicca- stay of postoperative management for severe pain. Epidural tion of bowel contents, which cause constipation and contrib- opioids may be administered in a single bolus or via continu- ute to postoperative ileus. Opioids also increase biliary tract ous infusions. They are usually combined with local anesthet- pressure. Finally, opioids may inhibit urinary bladder func- ics in a continuous epidural infusion to enhance analgesia.37 tion, thereby increasing the risk of urinary retention. Several long-acting, slow-release oral opioids are currently available, but their role (in particular, their safety) in the set- Mechanisms of Action ting of moderate to severe postoperative pain remains to be Opioids injected into the epidural or subarachnoid space established. In addition, modern principles of treatment cause segmental (i.e., selective, spinally mediated) analgesia increasingly emphasize the use of opioid-sparing analgesic by binding to opioid receptors in the dorsal horn of the spinal approaches to enhance recovery (see below). cord.38 The lipid solubility of an opioid, described by its par- tition coefficient, predicts its behavior when introduced into clinical application of systemic opioids the epidural or subarachnoid space. Opioids with low lipid Traditional IM dosing of opioids is a suboptimal means of solubility (i.e., hydrophilic opioids) have a slow onset of analgesia.34 IM dosing does not result in consistent blood action and a long duration of action. Opioids with high lipid levels, because opioids are absorbed at a variable rate from solubility (i.e., lipophilic opioids) have a quick onset of action the vascular bed of muscle. Moreover, administration of tra- but a short duration of action. This is attributable to more ditional IM regimens results in opioid concentrations that rapid diffusion across the dura into the spinal cord but exceed the concentrations required to produce analgesia only also more rapid systemic uptake and clearance via uptake into Table 5 Typical Intravenous Patient-Controlled Analgesia Regimens Drug Concentration Size of Bolus Lockout Interval (min) Agonists Morphine (1 mg/mL) Adult 0.5–2.5 mg 5–10 Pediatric 0.01–0.03 mg/kg (max. = 0.15 mg/kg/hr) 5–10 Fentanyl (0.01 mg/mL) Adult 10-20 ug 4–10 Pediatric 0.5–1 µ g/kg (max. = 4 µ g/kg/hr) 5–10 Hydromorphone (0.2 mg/mL) Adult 0.05–0.25 mg 5–10 Pediatric 0.003–0.005 mg/kg (max. = 0.02 mg/kg/hr) 5–10 01/09
  7. 7. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 7 epidural and spinal cord blood vessels. In fact, current Naloxone reverses the depressive respiratory effects of spinal evidence suggests that a major site of action of spinal lipo- opioids. In an apneic patient, 0.4 mg IV will usually restore philic opioids is not the spinal cord but the brain via systemic ventilation. If a patient has a depressed respiratory rate but is uptake.39 Thus, lipophilic opioids as sole epidural analgesic still breathing, small aliquots of naloxone (0.2 to 0.4 mg) can agents are becoming less frequently recommended. be given until the respiratory rate returns to normal. Subarachnoid opioids should be used when the required Nausea and vomiting are caused by transport of opioids to duration of analgesia after surgery is relatively short (< 24 hours) the vomiting center and the chemoreceptor trigger zone in because of typical single-injection delivery. When protracted the medulla via CSF flow or the systemic circulation. Nausea analgesia is required, epidural administration is preferred; can usually be treated with antiemetics or, if severe, with nal- repeated injections may be given through epidural catheters, or oxone (in 0.2 mg increments, repeated if necessary). continuous infusions may be used. Smaller doses of subarach- Pruritus is probably the most common side effect of the noid opioids are generally required to produce analgesia. Ordi- spinal opioids. Although not fully defined, the mechanism narily, no more than 0.1 to 0.25 mg of morphine should be used likely involves activation of “itch-specific” opioid receptors to provide 12 to 24 hours of analgesia. These doses, which are on spinal sensory neurons.45 Although pruritus is commonly about 10 to 20% of the size of comparably effective epidural treated with antihistamines, there is minimal evidence for doses, provide reliable pain relief with few side effects.40 Fen- mechanism-specific effectiveness. An alternative and proba- tanyl has also been extensively used in the subarachnoid space bly superior treatment is use of a mixed opioid agonist antag- in a dose range of 6.25 to 25 µ g to provide 3 to 6 hours of onist to directly block the opioid receptor–induced itching analgesia. Recently, an extended duration formulation of epidu- while maintaing opioid analgesias. Doses of 5 mg of nalbu- ral morphine has been commercially released.41–43 phine IV or 2 to 4 mg of butorphanol intranasally or IV every This formulation consists of morphine encased in multive- 6 hours is commonly used.45 sicular lipid with predictable sustained release. Clinical stud- The mechanism of spinal opioid–induced urinary retention ies have overall supported the efficacy and general safety of involves inhibition of volume-induced bladder contractions this formulation (10–15 mg doses) without demonstrating and blockade of the vesical reflex. Naloxone administration is marked superiority over conventional central neuraxial opioid the treatment of choice, although bladder catheterization is therapy. Thus, the role of this preparation remains to be sometimes required. determined. clinical application of epidural and Side Effects subarachnoid opioids The chief side effects associated with epidural and As stated earlier, subarachnoid opioids are limited in the subarachnoid opioids are respiratory depression, nausea and duration of analgesia because of typical single-injection deliv- vomiting, pruritus, and urinary retention.38,40,44 The poor lipid ery. Epidural administration allows prolonged delivery of opi- solubility of morphine is responsible for its protracted dura- oids, and typical regimens are listed in Table 6. However, tion of action but also allows morphine to undergo cephalad side effects from opioids are common, and it is better to com- migration in the cerebrospinal fluid (CSF). This migration bine epidural opioids with local anesthetics to obtain multi- can cause delayed respiratory depression, with a peak inci- modal and synergistic analgesia. This allows smaller doses of dence 3 to 10 hours after an injection. The high lipid solubil- both agents to be used with better analgesia and fewer side ity of lipophilic opioids such as fentanyl allows them to be effects. Typical regimens are listed in Table 7. absorbed into lipids close to the site of administration. Con- sequently, the lipophilic opioids do not migrate rostrally in epidural local anesthetics and other the CSF and cannot cause delayed respiratory depression. Of regional blocks course, the high lipid solubility of lipophilic opioids allows Local anesthetic neural blockade is unique among available them to be absorbed into blood vessels, which may cause analgesic techniques in that it may offer sufficient afferent early respiratory depression, as is commonly seen with sys- neural blockade, resulting in relief of pain; avoidance of seda- temic administration of opioids. Overall, the typical incidence tion, respiratory depression, and nausea; and, finally, efferent of respiratory depression is similar to that seen with systemic sympathetic blockade, resulting in increased blood flow to the opioids at approximately 0.2%.44 region of neural blockade.46 Table 6 Typical Dosing of Neuraxial Opoids Intrathecal or Subarachnoid Drug Single Dose Epidural Single Dose Epidural Continuous Infusion Fentanyl 5–25 µ g 50–100 µ g 25–100 µ g/hr Sufentanil 2–10 µ g 10–50 µ g 10–20 µ g/hr Morphine 0.1–0.3 mg 1–5 mg 0.1–1 mg/hr Hydromorphone — 0.5–1 mg 0.1–0.2 mg/hr Meperidine 10–30 mg 20–60 mg 10–60 mg/hr Lower doses may be effective when administered to the elderly or when injected in the cervical or thoracic region. Units vary across agents for single dose (mg versus µ g) and continuous infusion (mg/hr versus µ g/hr). 01/09
  8. 8. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 8 Table 7 Typical Patient-Controlled Epidural Analgesia Regimens Analgesic Solution Continuous Rate (mL/hr) Demand Dose (mL) Lockout Interval (min) 0.0625–0.125% bupivacaine + 2–5 µ g/mL 4–6 3–4 10–15 fentanyl 0.125–0.125% bupivacaine + 2–5 µ g//mL 3–5 2–3 12 sufentanil 0.1–0.2% ropivacaine + 2–4 µ g//mL 3–5 2–5 10–20 fentanyl Mechanism of Action clinical application of continuous epidural Local anesthetic neural blockade is a nondepolarizing block analgesia that reduces the permeability of cell membranes to sodium Typical regimens are listed in Table 7. As is similar with ions.47 Whether different local anesthetics have different IV PCA, patient-controlled epidural analgesia (PCEA) has effects on different nerve fibers is debatable. been demonstrated to provide superior analgesia, decreased analgesic consumption, and decreased side effects.51 The Choice of Drug safety of PCEA regimens for hospital wards has been well For optimal management of postoperative pain, the anes- documented.52 As all epidural analgesic agents are deliber- thetic agent should provide excellent analgesia of rapid onset ately segmental (limited in anatomic spread) in nature, it is and long duration without inducing motor blockade. The important for the vertebral site of epidural placement to various local anesthetic agents all meet one or more of these match the site of surgery. For example, lumbar epidurals criteria; however, the ones that come closest to meeting all of offer inferior analgesia to thoracic epidurals for thoracic sur- the criteria are bupivacaine, ropivacaine, and levobupivacaine. gery. Suggested epidural sites are also listed in Table 9. This should not preclude the use of other agents, because their efficacy has also been demonstrated. Ropivacaine and other regional analgesia techniques levobupivacaine may have a better safety profile, but the Intraperitoneal administration of local anesthetics cannot improvement may be relevant only when high intraoperative be recommended for typical postoperative analgesia, doses are given.47 because they are not efficacious,53 except in laparoscopic cholecystectomy.8,10 Intraincisional administration of bupi- Side Effects vacaine or other long-acting local anesthetics, which has The main side effects of epidural local anesthesia are hypo- negligible side effects and demands little or no surveillance, tension caused by sympathetic blockade, vagal overactivity, is recommended for patients undergoing relatively minor and decreased cardiac function (during a high thoracic block). procedures. Under no circumstances should epidural local anesthetics be Continuous administration of local anesthetics into the used before a preexisting hypovolemic condition is treated. wound via a catheter directly placed at the end of surgery is Hypotension may be treated with ephedrine, 10 to 15 mg IV, a simple and efficacious means to provide postoperative and fluids, with the patient tilted in a head-down position. analgesia. A recent systematic review noted that wound Atropine, 0.5 to 1.0 mg IV, may be effective during vagal catheters improved postoperative analgesia, reduced opioid overactivity. Urinary retention occurs in 20 to 100% of patients, and urinary catheterization is typically used during epidural anal- Table 8 Procedures for Maintenance of Epidural gesia. Motor blockade may delay mobilization; however, its Anesthesia for Longer than 24 Hours incidence can be reduced by using the weakest concentration 1. Administer appropriate drug in appropriate dosage at selected of local anesthetic that is compatible with adequate sensory infusion rate as determined by physician blockade. The routine complications associated with the epidural 2. Nurse evaluates vital signs and intake and output as required for a postoperative patient catheter are minimal when proper nursing protocols are fol- lowed [see Table 8]. The decision to employ epidural local 3. Nurse checks infusion pump hourly to ensure that it is function- anesthetics in such patients should be made only after the ing properly, that infusion rate is proper, and that alarm is on risks44,48 are carefully compared with the documented advan- 4. Nurse also assesses tages of such anesthetics.49,50 • Bladder—for distention, if patient is not catherized Spinal hematoma attributable to the combination of epidu- • Lower extremities—for status of motor function ral analgesia and anticoagulants is rare, but the risk may be • Central nervous system—for signs of toxicity or respiratory depression increased by specific agents. Guidelines on the use of epidural • Skin integrity on back (breakdown may occur if motor func- analgesia and anticoagulation are currently listed on the tion is not present) American Society of Regional Anesthesia and Pain Medicine • Tubing and dressing (disconnection of tubing or dislodg- Web site.48 Most anticoagulants can be safely managed with ment of catheter may occur) epidural analgesia; however, special care must be taken with 5. Every 48 hr, the catheter dressing should be removed, the cath- thrombolytics, low-molecular-weight heparins, and newer eter entrance site cleaned, and topical antibiotic applied (much antiplatelet, antithrombin, and anti–factor Xa agents. as in care of a central venous catheter) 01/09
  9. 9. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 9 Table 9 Recommended Location of Catheter Insertion for Surgical Procedures Congruent Epidural Catheter Location of Incision Examples of Surgical Procedures Placement Thoracic Lung reduction, radical mastectomy, thoracotomy, thymectomy T4–8 Upper abdominal Cholecystectomy, esophagectomy, gastrectomy, hepatic section, Whipple T6–8 procedure Middle abdominal Cystoprostatectomy, nephrectomy T7–10 Lower abdominal Abdominal aortic aneurysm repair, colectomy, radical prostatectomy, T8–11 total abdominal hysterectomy Lower extremity Femoropopliteal bypass, total hip or total knee replacement L1–4 L = lumbar; T = thoracic. use, and decreased opioid-related side effects in a variety of any agent or agents over the others, and selection therefore procedures.13 However, there is still a need for more may depend on the convenience of delivery, duration, and procedure-specific data before general recommendations can cost.66 All of the NSAIDs have potentially serious side effects: be made as a wide variety of surgical procedures, catheter GI and surgical site hemorrhage, renal failure, impaired bone locations, and analgesic regimens were included in the sys- healing, and asthma. The endoscopically verified superficial tematic review. ulcer formation seen within 7 to 10 days after the initiation Continuous peripheral nerve blocks are growing in popular- of NSAID therapy is not seen with selective COX-2 inhibitor ity, and the analgesic treatment may be continued after dis- treatment in volunteers. The clinical relevance of these find- charge.54,55 A systematic review has documented multiple ings for perioperative treatment remains to be established, benefits from the use of continuous perineural analgesia versus however, given that acute severe GI side effects (bleeding, systemic opioids, such as reduced pain scores at rest and with perforation) are extremely rare in elective cases. activity, reduced opioid use, reduced opioid-related side Because prostaglandins are important for regulation of effects, and increased patient satisfaction.54 Use of outpatient water and mineral homeostasis by the kidneys in the dehy- perineural analgesia is also growing in popularity, and studies drated patient, perioperative treatment with NSAIDs, which have observed that this form of analgesia reduces unplanned inhibit prostaglandin synthesis, may lead to postoperative hospital admission after ambulatory procedures, improves renal failure. So far, specific COX-2 inhibitors have not been patients quality of life at home, and may facilitate conversion demonstrated to be less nephrotoxic than conventional of hospital procedures to short-stay procedures (e.g., total NSAIDs.62,67 Although little systematic evaluation has been knee replacement).56 A growing body of literature surveying done, extensive clinical experience with NSAIDs suggests the use of thousands of perineural catheters for postoperative that the renal risk is not substantial.68 Nonetheless, conven- analgesia documents a low incidence of complications and tional NSAIDs and COX-2 inhibitors should be used with overall safety of this technique.57 More recently, a high-volume caution in patients who have preexisting renal dysfunction.62 infiltration technique with dilute concentrations of local anes- Although conventional NSAIDs prolong bleeding time and thetics with or without adjuvants seems promising because of inhibit platelet aggregation, there generally does not seem to its apparent efficacy, simplicity, and safety.58,59 nsaids, cox-2 inhibitors, and acetaminophen Table 10 Typical Dosing for Common NSAIDs, COX-2 Inhibitors, and Acetaminophen NSAIDs and COX-2 inhibitors are modest analgesics that have both peripheral and central analgesic mechanisms and Typical Dose for Maximum Postoperative Recommended antiinflammatory effects [see Table 10]. Although these agents Drug Analgesia Dose (mg/day) are typically less effective as sole analgesic agents than opi- oids,60 they have an excellent efficacy to safety profile and are Acetaminophen 650–1,000 mg q 6 hr 4,000 generally recommended after all kinds of operations for low- Celecoxib 100–200 mg q 12 hr 400 risk patients.61,62 Several reviews and systematic reviews report Diclofenac 50 mg q 8 hr 150 that NSAIDs and COX-2 inhibitors decrease systemic mor- Ibuprofen 400 mg q 6 hr 3,200 phine use by approximately 13 to 18 mg over a 24-hour period.61,62 More importantly, these reviews indicate that Indomethacin 25–50 mg q 8 hr 200 NSAIDs decrease pain scores by approximately 1 cm on a 10 cm Ketorolac 10 mg q 4–6 hr 40 visual analogue scale pain score and reduce opioid-related side Ketorolac 15–30 mg q 6 hr 120 effects of sedation and nausea by approximately 30%. Conven- (intravenous) tional NSAIDs inhibit both COX-1 and COX-2. Selective Meloxicam 7.5–15 mg q day 15 COX-2 inhibitors, which do not inhibit COX-1, have the potential to achieve analgesic efficacy comparable to that of Naproxen 250 mg q 6–8 hr 1,375 conventional NSAIDs but with fewer minor side effects.63–65 Paracetamol 1,000 mg q 6 hr 4,000 Only a few of the NSAIDs may be given parenterally. The (intravenous) data now available on the use of NSAIDs for postoperative COX-2 = cyclooxygenase; NSAIDs = nonsteroidal antiinflammatory pain are insufficient to allow definitive recommendation of drugs. 01/09
  10. 10. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 10 be a clinically significant risk of increased bleeding. However, of serotonin and norepinephrine.78 It can be used as an intra- in some procedures for which strict hemostasis is critical venous analgesic but is less potent than opioids (morphine, (e.g., tonsillectomy, cosmetic surgery, and eye surgery), these meperidine)79 and is a poor sole agent for control of postop- drugs have been shown to increase the risk of bleeding com- erative pain.80 plications and should therefore be replaced with COX-2 Several systematic reviews have suggested that some anal- inhibitors, which do not inhibit platelet aggregation.69 The gesic and perioperative opioid-sparing effects can be achieved observation that prostaglandins are involved in bone and by adding an N-methyl-d-aspartate (NMDA) receptor wound healing has given rise to concern about potential side antagonist (e.g., ketamine), gabapentin, or pregabalin [see effects in surgical patients. Although there is experimental Combination Regimens, below].34,81 evidence that both conventional NSAIDs and COX-2 inhib- itors can impair bone healing,70 the clinical data available at transcutaneous electrical nerve stimulation present are insufficient to document increased wound or Transcutaneous electrical nerve stimulation (TENS) is the bone healing failure with these drugs.71 This is a particularly application of a mild electrical current through the skin sur- important issue for future study in that many orthopedic sur- face to a specific area, such as a surgical wound, to achieve geons remain reluctant to use NSAIDs. pain relief; the exact mechanism whereby it achieves this Currently, there is widespread concern about the increased effect is yet to be explained but may involve spinal gating and risk of cardiovascular complications associated with long-term activation of opioid receptors. Although several randomized treatment with selective COX-2 inhibitors. Generally, such controlled trials have reported efficacy after inguinal herni- side effects have appeared only after 1 to 2 years of treatment otomy,82 thoracotomy,83 and other procedures,84 the specific and led to the withdrawal of rofecoxib in 2004 and valdecoxib values and the proper uses of the various stimulation frequen- in 2005 from the US market.72 In the past few years, however, cies, waveforms, and current intensities have not been deter- two studies of patients undergoing coronary artery bypass mined. In addition, blinding of subjects is difficult with TENS grafting (CABG) found that the risk of cardiovascular com- studies, and this effect of bias is difficult to assess. Overall, plications was increased significantly (two- to threefold) in the effect of TENS on acute pain is too imprecise to warrant this setting and led to the label change for COX-2 inhibitors a recommendation for routine use.85 and NSAIDs indicating that these agents are contraindicated in CABG patients.72 The larger question is whether these combination regimens drugs should also be contraindicated for perioperative use, or Because no single pain treatment modality is optimal, com- at least used with caution, in high-risk cardiovascular patients bination regimens (e.g., balanced analgesia or multimodal who are undergoing procedures other than CABG. At pres- treatment) offer major advantages over single-modality regi- ent, the data are insufficient to allow final conclusions; none- mens, whether by maintaining or improving analgesia, by theless, reviews suggest that the benefits of short-term use of reducing side effects, or by doing both.86 Combinations of these agents in patients without cardiovascular risk factors epidural local anesthetics and morphine,15,44 of NSAIDs and probably outweigh the potential (low) risk of complications. opioids,66,87,88 of NSAIDs and acetaminophen,73,74 of acet- Until further studies are performed, use in patients with car- aminophen and opioids,89 of acetaminophen and tramadol,90 diovascular risk factors should be cautious.72 and of a selective COX-2 inhibitor and gabapentin91 or pre- Acetaminophen also possesses analgesic capability, both gabalin81 have been reported to have additive effects. At pres- peripherally and centrally. Its analgesic effect is somewhat (about ent, information on other combinations (involving ketamine, 20 to 30%) weaker than those of conventional NSAIDs and clonidine, glucocorticoids, and other agents) is too sparse to COX-2 inhibitors. For example, use of acetaminophen typically allow firm recommendations; however, multimodal analgesia reduces morphine consumption by approximately 9 mg over a is undoubtedly promising, and multidrug combinations 24-hour period,61 which may be insufficient to significantly should certainly be explored further. reduce opioid-related side effects or dramatically improve anal- The potential of combination regimens is especially intrigu- gesia. However, acetaminophen lacks the side effects typical of ing with respect to the concept of perioperative opioid-sparing NSAIDs.62 Combining acetaminophen with NSAIDs may analgesia. The use of one or several nonopioid analgesics in improve analgesia, especially in smaller and moderate-sized such regimens may enhance recovery in that the concomitant operations73,74; accordingly, this agent is recommended as a reduction in the opioid dosage will lead to decreased nausea, basic component of multimodal analgesia in all operations. vomiting, and sedation.92–95 Both the adverse events associated with postoperative opioid analgesia and the relatively high costs other analgesics of such analgesia argue for an opioid-sparing approach.96,97 The Glucocorticoids are powerful antiinflammatory agents and ability to reduce opioid-related and non–opioid-related side have proven analgesic value in less extensive procedures,75,76 effects by use of multimodal analgesia may become especially especially dental, laparoscopic, and arthroscopic operations. attractive for several reasons. First, there is growing evidence In addition, they have profound antiemetic effects.77 Con- that the use of opioids as sole analgesics can lead to opioid- cerns about possible side effects in the setting of perioperative induced hyperalgesia, whereby overstimulation of opioid recep- administration have not been borne out by the results of ran- tors creates a nociceptive state (i.e., opioids increase sensitivity domized studies.75,76 to painful stimuli).98 Also, in light of the JCAHO pain initiative Tramadol is a weak analgesic that has several relatively and overall increased focus on reducing pain,1 a concern exists minor side effects (e.g., dizziness, nausea, and vomiting) and that these initiatives may precipitate increased use of opioids possesses weak opioid agonist activity and inhibits reuptake and thereby an increased risk of side effects.99,100 01/09
  11. 11. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 11 Discussion Physiologic Mechanisms of Acute Pain or augmentation of this descending system enhances analgesia. The noxious stimuli from iatrogenic surgical injury or Epidural-intrathecal administration of alpha-adrenergic agonists accidental trauma set a cascade of events in motion cumu- (e.g., clonidine) or of anticholinesterases (e.g., neostigmine) lating in the perception of “pain.” Many interrelated com- works in this manner to provide pain relief.94 ponents contribute to the processing of nociceptive stimuli. spinal reflexes Clinicians should recognize that the neurobiology of noci- ception is extremely complex, with multiple levels of redun- Nociception may be enhanced by spinal reflexes that affect dancy, such that there is no “hardwired” or “final common” the environment of the nociceptive nerve endings. Thus, pathway for the process of nociception of acute pain. The tissue damage may provoke an afferent reflex that causes basic mechanisms are (1) afferent transmission of nocicep- muscle spasm in the vicinity of the injury, thereby increasing tive stimuli through the peripheral nervous system after nociception. Similarly, sympathetic reflexes may cause tissue damage, (2) modulation of these injury signals by decreased microcirculation in injury tissue, thereby generat- control systems in the dorsal horn, and (3) modulation of ing smooth muscle spasm, which amplifies the sensation. the ascending transmission of pain stimuli by a descending control system originating in the brain [see Figure 1].101–103 postinjury changes in peripheral and central nervous systems peripheral pain receptors and neural After an injury, the afferent nociceptive pathways undergo transmission to the spinal cord physiologic, anatomic, and chemical changes.102,103 These changes Peripheral pain receptors (nociceptors) can be identified by include increased sensitivity on the part of peripheral nociceptors, function but cannot be distinguished anatomically. The as well as the growth of sprouts from damaged nerve fibers that responsiveness of peripheral pain receptors may be enhanced become sensitive to mechanical and alpha-adrenergic stimuli and by endogenous analgesic substances (e.g., prostaglandins, eventually begin to fire spontaneously. Moreover, excitability serotonin, bradykinin, nerve growth factor, and histamine), may be increased in the spinal cord, which leads to expansion of as well as by increased efferent sympathetic activity.101 Anti- receptive fields in dorsal horn cells. Such changes may lower pain dromic release of substance P may amplify the inflammatory thresholds, may increase afferent barrage in the late postinjury response and thereby increase pain transmission. The periph- state, and, if normal regression does not occur during convales- eral mechanisms of visceral pain are different from somatic or cence, may contribute to a chronic pain state.102 neuropathic nociception and likely involve transient receptor Neural stimuli have generally been considered to be the potential vanilloid 1 receptors, acid-sensing ion channels, and main factor responsible for initiation of spinal neuroplasticity; tachykinins.104 Peripheral opioid receptors have been demon- however, it now appears that such neuroplasticity may also be strated to appear in inflammation on the peripheral nerve mediated by cytokines released as a consequence of COX-2 terminals but probably have little clinical relevance.31–33 induction.103 Improved understanding of the mechanisms of Somatic nociceptive input is transmitted to the CNS through pain may serve as a rational basis for future drug development A-delta and C fibers, which are small in diameter and either and may help direct therapy away from symptom control and unmyelinated or thinly myelinated. Visceral pain is transmit- toward mechanism-specific treatment.107 ted through afferent sympathetic pathways; the evidence that In experimental studies, acute pain behavior or hyperexcit- afferent parasympathetic pathways play a role in visceral noci- ability of dorsal horn neurons may be eliminated or reduced if ception is inconclusive.104,105 the afferent barrage is prevented from reaching the CNS. Pre- injury neural blockade with local anesthetics or opioids can dorsal horn control systems and modula- suppress excitability of the CNS; this is called preemptive anal- tion of incoming signals gesia. Although this has been a consistent finding in laboratory All incoming nociceptive traffic synapses in the gray matter of studies, clinical studies have been less dramatic. A critical anal- the dorsal horn (Rexed laminae I to IV). Several substances may ysis of controlled clinical studies that compared the efficacy of be involved in primary afferent transmission of nociceptive stimuli analgesic regimens administered preoperatively with the effi- in the dorsal horn: substance P, enkephalins, somatostatin, neu- cacy of the same regimens administered postoperatively con- rotensin, g-aminobutyric acid (GABA), glutamic acid, angiotensin cluded that preemptive analgesia does not always provide a II, vasoactive intestinal polypeptide (VIP), and cholecystokinin clinically significant increase in pain relief.108,109 Nonetheless, it octapeptide (CCK-8).102,106 From the dorsal horn, nociceptive is important that pain treatment be initiated early to ensure information is transmitted through the spinothalamic tracts to the that patients do not wake up with high-intensity pain. hypothalamus, through spinoreticular systems to the brainstem and reticular formation, and finally to the cerebral cortex. Effects of Pain Relief descending pain control system s elected p hys iologic res p ons es to oper ation A descending control system for sensory input originates in the brainstem and reticular formation and in certain higher brain Cardiovascular areas. The main neurotransmitters in this system are norepi- It has traditionally been thought that an imbalance of myo- nephrine, serotonin, acetylcholine, and enkephalins. Stimulation cardial oxygen supply and demand, such as an increase in 01/09
  12. 12. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 12 Perception of Pain Trauma Capillary To the Limbic System Descending Inhibitory Pathway Neurotransmitters at Dorsal Horn Level: Norepinephrine Release of Serotonin Substance P Enkephalins Histamine Serotonin Primary Afferent Bradykinin Neurotransmitter Prostaglandins Candidates Substance P Spinothalamic Tract L-Glutamate GABA Release of VIP CCK-8 Sensory Nerve Norepinephrine Somatostatin Muscle Motor of other Efferent Nerve Segmental Reflexes: Increased Skeletal Muscle Tension Decreased Chest Compliance More Nociceptive Input Increased Sympathetic Tone Decreased Gastric Mobility IIeus, Nausea, Vomiting Figure 1 Shown are the major neural pathways involved in nociception. Nociceptive input is transmitted from the periphery to the dorsal horn via A-delta and C fibers (for somatic pain) or via afferent sympathetic pathways (for visceral pain). It is then modulated by control systems in the dorsal horn and sent via the spinothalamic tracts and spinoreticular systems to the hypothalamus, to the brainstem and reticular formation, and eventually to the cerebral cortex. Ascending transmission of nociceptive input is also modulated by descending inhibitory pathways originating in the brain and terminating in the dorsal horn. Nociception may be enhanced by reflex responses that affect the environment of the nociceptors, such as smooth muscle spasm. CCK = cholecystokinin-octapeptide; GABA = γ -aminobutyric acid; VIP = vasoactive intestinal peptide. demand (e.g., increase in heart rate or blood pressure) or a uncontrolled postoperative pain may be especially detrimen- decrease in supply (e.g., decreased coronary blood flow to the tal and contribute to cardiac morbidity through activation of vulnerable subendocardial areas), may contribute to periop- the sympathetic nervous system, other surgical stress erative cardiac events, particularly in patients with decreased responses, and the coagulation cascade. Increased sympa- cardiac reserve.110 Although many factors may contribute to thetic nervous system activity can increase myocardial oxygen an imbalance of myocardial oxygen supply and demand, demand by increasing heart rate, blood pressure, and 01/09
  13. 13. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 13 contractility or even decrease myocardial oxygen supply, other functions, including tissue repair, autoimmune which, in turn, may lead to angina, dysrhythmias, and areas regulation, arteriosclerosis, and tumor growth and metasta- of myocardial infarction.110 In addition, sympathetic activa- sis.114 Nevertheless, the primary components of the coagula- tion may enhance perioperative hypercoagulability, which tion systems comprise cellular (e.g., platelets, endothelial may contribute to perioperative coronary thrombosis or vaso- cells, monocytes, and erythrocytes) and molecular (e.g., spasm, thus reducing myocardial oxygen supply.111 coagulation factors and inhibitors, fibrinolysis factors and inhibitors, adhesive and intercellular proteins, acute-phase Pulmonary proteins, immunoglobulins, phospholipids, prostaglandins, The pathophysiology of pulmonary dysfunction after sur- and cytokines) components.114 The normal process of coag- gery is multifactorial. Relevant factors include disruption of ulation involves several steps, including initiation (damaged normal respiratory muscle activity, which may result from vascular endothelium expresses tissue factor, which ulti- either surgery or anesthesia, reflex inhibition of phrenic nerve mately leads to generation of thrombin), amplification (aug- activity with subsequent decrease in diaphragmatic function, mentation of the effects of thrombin), propagation (formation and uncontrolled postoperative pain, which may contribute of clot), and stabilization (formation of a stable fibrin mesh- to voluntary inhibition of respiratory activity, or splinting.112 work that protects clot from fibrinolytic attack).114 However, Although the pathophysiology of breathing and respiratory following surgery, the normal process of coagulation may muscle function following surgery is complex, it is clear that become unbalanced, which may result in a tendency toward anesthetic or analgesic agents administered in the periopera- thrombosis. Immediately after surgical incision, there are tive period affect the central regulation of breathing and increases in the levels of tissue factor, tissue plasminogen activities of respiratory muscles. This incoordination of respi- activator, plasminogen activator inhibitor–1, and von Will- ratory muscle function (which may last well into the postop- ebrand factor, which contribute to a hypercoagulable and erative period) will impair lung mechanics, increasing the risk hypofibrinolytic state postoperatively.114 Many of these det- of hypoventilation, atelectasis, and pneumonia. Visceral stim- rimental responses may be reduced by excellent postopera- ulation may decrease phrenic motoneuron output, which tive analgesia and in particular by the sympathetic and results in a decrease in diaphragmatic descent and lung afferent block provided by thoracic epidural analgesia with volumes.112 local anesthetics. Gastrointestinal postoperative morbidity Although decreased GI motility is expected after abdomi- Despite excellent theoretical reasons why high-quality nal surgery, return of GI function usually occurs within sev- analgesia should improve postoperative physiology and out- eral days postoperatively. Some patients will develop paralytic comes, the effects of nociceptive blockade and pain relief ileus, a protracted and more severe state of GI immotility. on postoperative morbidity remain controversial.16 There Although the pathophysiology of postoperative ileus and are several likely reasons why these effects are difficult to decreased GI motility is multifactorial, the primary mecha- assess. Primarily, surgical techniques and perioperative care nisms include neurogenic (spinal, supraspinal adrenergic are constantly evolving and improving, with subsequent pathways), inflammatory (i.e., local inflammatory responses reduction in baseline morbidity and mortality. Thus, the initiate neurogenic inhibitory pathways), and iatrogenic positive effects of analgesia on outcomes may be apparent pharmacologic (e.g., opioids) mechanisms.113 In the acute only on selected high-risk patients or procedures. Several postoperative phase, neurogenic (spinal and supraspinal) systematic reviews have examined this question and have mechanisms are primary mediators of decreased GI motil- reached the following conclusions. For open major vascular ity.113 Activation of splanchic afferents and increased sympa- and thoracic procedures, there is good evidence from sys- thetic outflow, along with the possible use of opioids, are the tematic reviews and large randomized controlled trials that predominant mechanisms for decreased GI motility immedi- thoracic epidural analgesia may reduce cardiovascular and ately following surgery. However, over the subsequent post- pulmonary morbidity when compared with systemic opi- operative days, a prolonged phase of postoperative ileus oids.16 There is good evidence from meta-analyses that occurs. The presumed etiology of the latter is distinct and intraoperative spinal or epidural local anesthetics in lower- involves an enteric molecular inflammatory response that body procedures reduce estimated blood loss by about impairs local neuromuscular function and activates neuro- 30%.17,115 Finally, the duration of postoperative ileus is genic inhibitory pathways.113 Our understanding of the reduced by approximately 24 to 36 hours with the use of mechanisms of postoperative ileus is not complete, and it is epidural analgesia with local anesthetic–containing solu- likely that these three mechanisms are not discrete phenom- tions after major open abdominal procedures.16 This effect ena but interrelated. may be of major significance in that reduction of ileus allows earlier oral nutrition,50 which has been demonstrated Coagulation to improve outcome. It is recognized that hypercoagulability occurs in associa- Another key feature in the difficulties assessing the impact tion with surgical procedures. Although the pathophysiology of postoperative analgesia is that most studies to date have of coagulation-related events (e.g., formation of deep vein focused on the effects of a single factor (i.e., epidural analge- thrombosis has essentially been unchanged since Virchow’s sia) on overall postoperative morbidity. In current medical initial description of the triad of stasis, blood vessel injury, practice, this is probably too simplistic an approach as overall and hypercoagulability, our current understanding of the postoperative outcome is known to be determined by multi- coagulation system is that it is a complex system with many ple factors.116–118 Besides postoperative pain relief, reinforced 01/09
  14. 14. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 14 psychological preparation of the patient, reduction of stress nists, and anticonvulsant analgesia adjuncts such as gabapen- by performing neural blockade or opting for minimal invasive tin.61,124,125 Future studies will need to define optimal strategies procedures, and enforcement of early oral postoperative feed- for high-risk procedures and patients. ing and mobilization may all play a significant role in deter- mining outcome.118 Prevention of intraoperative hypothermia, barriers to effective postoperative analgesia avoidance of fluid overloading, and avoidance of hypoxemia In general, multiple advisory and supervisory organizations may be important as well.118,119 Therefore, although adequate (e.g., JCAHO, World Health Organization) recognize the pain relief is obviously a prerequisite for good outcome, the importance of adequate pain control.1 Partially in response to best results are likely to be achieved by combining analgesia these initiatives, there has been a marked increase in the cre- with all of the aforementioned factors in a multimodal reha- ation and requirement of acute pain treatment services within bilitation effort. hospitals across the world.126 Work continues on attempting to create efficient and simple delivery techniques and tech- development and prevention of chronic nologies for postoperative analgesia. In addition to economic postoperative pain constraints, significant concerns regarding potential for opioid Although not all nociceptive input results in a pathologic tolerance and addiction remain as a barrier.1 Continued expo- process, a substantial percentage of patients who undergo sure of an opioid receptor to high concentrations of opioid will certain surgical procedures will exhibit prolonged central cause tolerance. Tolerance is the progressive decline in an sensitization and chronic pain [see Table 11]. Pathologic opioid’s potency with continuous use, so higher and higher nociceptive input may cause central sensitization, which is concentrations of the drug are required to cause the same marked by hyperexcitable spinal neurons that exhibit a analgesic effect. Physical dependence refers to the production decreased threshold for activation, increased and prolonged of an abstinence syndrome when an opioid is withdrawn. It is response to noxious input, expansion of receptive fields, defined by the World Health Organization as follows: possible spontaneous activity, and activation by normally A state, psychic or sometimes also physical, resulting from non-noxious stimuli.120 interactions between a living organism and a drug, char- Induction and maintenance of central sensitization empha- acterized by behavioural and other responses that always size different receptor-neurotransmitter combinations, includ- include a compulsion to take the drug on a continuous or ing NMDA receptors, prostaglandins, and neuropeptides periodic basis in order to experience its psychic effects, (substance P, calcitonin gene–related peptide, neurokinin A).121 and sometimes to avoid discomfort from its absence.127 Ultimately, transcriptional changes (including induction of genes), structural changes in synaptic connections (e.g., con- This definition is very close to the popular concept of addic- tact between low-threshold afferent and nociceptive neurons), tion. It is important, however, to distinguish addiction (imply- and loss of inhibitory interneurons may result in a persistent ing compulsive behavior and psychological dependence) from state of central sensitization.122 tolerance (a pharmacologic property) and from physical Multiple studies and reviews have noted that more severe dependence (a characteristic physiologic effect of a group of acute postoperative pain is a risk factor for development of drugs). Physical dependence does not imply addiction. More- chronic postoperative pain.61,123 Although optimal strategies over, tolerance can occur without physical dependence; the for prevention of chronic pain have not been identified, converse does not appear to be true. The possibility that the promising modalities include preemptive regional analgesia medical administration of opioids could result in a patient such as thoracic epidural local anesthetics, NMDA antago- becoming addicted has generated much debate about the use Table 11 Approximate Incidences and Risk Factors for Development of Postoperative Chronic Pain Surgical Procedure Incidence of Chronic Pain (%) Risk Factors Thoracotomy 30–70 Increased acute pain Open vs thoracoscopic Not using thoracic epidural analgesia with local anesthetics Intercostal nerve injury Mastectomy 11–60 Increased acute pain Increased acute opioid consumption Immediate adjuvant radiation therapy Axillary dissection vs sentinel node biopsy Inguinal hernia repair 0–37 Increased acute pain Preoperative pain Female gender Surgery for recurrent hernia Open vs laparoscopic 01/09
  15. 15. © 2009 BC Decker Inc ACS Surgery: Principles and Practice 1 BASIC SURGICAL AND PERIOPERATIVE CONSIDERATIONS 6 POSTOPERATIVE PAIN — 15 of opioids. In a prospective study of 12,000 hospitalized treatment techniques, the risks attendant on the procedures patients receiving at least one strong opioid for a protracted under consideration, and the cost to the patient. It is to be period, there were only four reasonably well-documented hoped that our growing understanding of basic pain mecha- cases of subsequent addiction, and in none of these was there nisms and appropriate therapy, combined with the promising a history of previous substance abuse.128 Thus, the iatrogenic data supporting the idea that adequate inhibition of surgically production of opioid addiction is very rare. It is hoped that induced nociceptive stimuli may reduce postoperative mor- continued physician and patient education will reduce this bidity, will stimulate more surgeons to turn their attention to barrier to high-quality postoperative analgesia. this area. Effective control of postoperative pain, combined with a high degree of surgical expertise and the judicious use of other perioperative therapeutic interventions within the Conclusion context of multimodal postoperative rehabilitation, is certain The choice of therapeutic intervention for acute postopera- to improve acute and long-term patient outcomes. tive pain is determined largely by the nature of the patient’s problem, the resources available, the efficacy of the various Financial Disclosures: None Reported References 1. Brennan F, Carr DB, Cousins M. Pain man- based analgesic regimens on postoperative encouragement and instruction of patients. a agement: a fundamental human right. gastrointestinal paralysis, PONV and pain study of doctor-patient rapport. N Engl J Anesth Analg 2007;105:205–21. after abdominal surgery. Cochrane Database Med 1964;270:825–7. 2. Joint Commission on Accreditation of Syst Rev 2000;CD001893. 28. Wang SM, Kain ZN, White PF. Acupunc- Healthcare Organizations. Pain management 16. Liu SS, Wu CL. Effect of postoperative anal- ture analgesia: II. Clinical considerations. standards. Available at: http://www.jcaho.org/ gesia on major postoperative complications: Anesth Analg 2008;106:611–21. accredited+organizations/hospitals/standards/ a systematic update of the evidence. Anesth 29. Inturrisi CE. Clinical pharmacology of opi- revisions/2001/pain+management1.htm Analg 2007;104:689–702. oids for pain. Clin J Pain 2002;18:S3–13. (accessed December 30, 2008). 17. Richman JM, Rowlingson AJ, Maine DN, 30. Delaney CP, Wolff BG, Viscusi ER, et al. 3. Huang N, Cunningham F, Laurito CE, Chen et al. Does neuraxial anesthesia reduce intra- Alvimopan, for postoperative ileus follow- C. Can we do better with postoperative pain operative blood loss? A meta-analysis. J Clin ing bowel resection: a pooled analysis of management? Am J Surg 2001;182:440–8 Anesth 2006;18:427–35. phase III studies. Ann Surg 2007;245: 4. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. 18. Singelyn FJ, Deyaert M, Joris D, et al. 355–63. Postoperative pain experience: results from a Effects of intravenous patient-controlled 31. Picard PR, Tramer MR, McQuay HJ, Moore national survey suggest postoperative pain analgesia with morphine, continuous epidu- RA. Analgesic efficacy of peripheral opioids continues to be undermanaged. Anesth ral analgesia, and continuous three-in-one (all except intra-articular): a qualitative sys- Analg 2003;97:534–40. block on postoperative pain and knee reha- tematic review of randomised controlled tri- 5. Angst MS, Clark JD. Opioid-induced hyper- bilitation after unilateral total knee arthro- als. Pain 1997;72:309–18. algesia: a qualitative systematic review. plasty. Anesth Analg 1998;87:88–92. 32. Rosseland LA. No evidence for analgesic Anesthesiology 2006;104:570–87. 19. Evans H, Steele SM, Nielsen KC, et al. effect of intra-articular morphine after knee 6. Kehlet H. Procedure-specific postoperative Peripheral nerve blocks and continuous arthroscopy: a qualitative systematic review. pain management. Anesthesiol Clin North catheter techniques. Anesthesiol Clin North Reg Anesth Pain Med 2005;30:83–98. Am 2005;23:203–10. Am 2005;23:141–62. 33. Janson W, Stein C. Peripheral opioid analge- 7. Gray A, Kehlet H, Bonnet F, Rawal N. Pre- 20. Salinas FV, Liu SS, Mulroy MF. The effect sia. Curr Pharm Biotechnol 2003;4:270–4. dicting postoperative analgesia outcomes: of single-injection femoral nerve block ver- 34. Liu SS, Wu CL. The effect of analgesic tech- NNT league tables or procedure-specific sus continuous femoral nerve block after nique on postoperative patient-reported out- evidence? Br J Anaesth 2005;94:710–4. total knee arthroplasty on hospital length of comes including analgesia: a systematic 8. Bisgaard T. Analgesic treatment after laparo- stay and long-term functional recovery review. Anesth Analg 2007;105:789–808. scopic cholecystectomy: a critical assessment of within an established clinical pathway. 35. Viscusi ER, Siccardi M, Damaraju CV, the evidence. Anesthesiology 2006;104:835–46. Anesth Analg 2006;102:1234–9. et al. The safety and efficacy of fentanyl 9. Fischer HB, Simanski CJ, Sharp C, et al. A 21. Horlocker TT, Kopp SL, Pagnano MW, iontophoretic transdermal system com- procedure-specific systematic review and Hebl JR. Analgesia for total hip and knee pared with morphine intravenous patient- consensus recommendations for postopera- arthroplasty: a multimodal pathway featur- controlled analgesia for postoperative pain tive analgesia following total knee arthro- ing peripheral nerve block. J Am Acad management: an analysis of pooled data plasty. Anaesthesia 2008;63:1105–23. Orthop Surg 2006;14:126–35. from three randomized, active-controlled 10. Procedure Specific Postoperative Pain Man- 22. Pellino TA, Gordon DB, Engelke ZK, et al. clinical studies. Anesth Analg 2007;105: agement. Available at: http://www.postoppain. Use of nonpharmacologic interventions for 1428–36. org (accessed December 30, 2008). pain and anxiety after total hip and total 36. Panchal SJ, Damaraju CV, Nelson WW, 11. Block BM, Liu SS, Rowlingson AJ, et al. knee arthroplasty. Orthop Nurs et al. System-related events and analgesic Efficacy of postoperative epidural analgesia: 2005;24:182–90; quiz 191–2. gaps during postoperative pain management a meta-analysis. JAMA 2003;290:2455–63. 23. White PF. Use of alternative medical thera- with the fentanyl iontophoretic transdermal 12. Joshi GP, Bonnet F, Shah R, et al. A system- pies in the perioperative period: is it time to get system and morphine intravenous patient- atic review of randomized trials evaluating on board? Anesth Analg 2007;104:251–4. controlled analgesia. Anesth Analg regional techniques for postthoracotomy 24. National Center for Complementary and 2007;105:1437–41. analgesia. Anesth Analg 2008;107:1026–40. Alternative Medicine. Available at: http:// 37. Walker SM, Goudas LC, Cousins MJ, Carr 13. Liu SS, Richman JM, Thirlby RC, Wu CL. nccam.nih.gov/news/newsletter/2006_fall/ DB. Combination spinal analgesic chemo- Efficacy of continuous wound catheters hospitals.htm (accessed December 30, 2008). therapy: a systematic review. Anesth Analg delivering local anesthetic for postoperative 25. Anesthesia Patient Safety Foundation. Available 2002;95:674–715. analgesia: a quantitative and qualitative sys- at: http://www.apsf.org/assets/Documents/win- 38. Rawal N. Epidural and spinal agents for tematic review of randomized controlled tri- ter2007.pdf (accessed December 30, 2008). postoperative analgesia. Surg Clin North als. J Am Coll Surg 2006;203:914–32. 26. Institute for Healthcare Improvement. Avail- Am 1999;79:313–44. 14. Liu SS, Block BM, Wu CL. Effects of able at: http://www.ihi.org/IHI/Topics/Patient 39. Bernards CM. Recent insights into the phar- perioperative central neuraxial analgesia on Safety/MedicationSystems/Changes/Individual macokinetics of spinal opioids and the rele- outcome after coronary artery bypass sur- Changes/Consider+Non-Pharmacological+ vance to opioid selection. Curr Opin gery: a meta-analysis. Anesthesiology 2004;101: Interventions+for+Pain+and+Anxiety.htm Anaesthesiol 2004;17:441–7 153–61. (accessed December 30, 2008). 40. Rathmell JP, Lair TR, Nauman B. The role 15. Jorgensen H, Wetterslev J, Moiniche S, Dahl 27. Egbert LD, Battit GE, Welch CE, Bartlett of intrathecal drugs in the treatment of acute JB. Epidural local anaesthetics versus opioid- MK. Reduction of postoperative pain by pain. Anesth Analg 2005;101:S30–43. 01/09

×